AbstractObjectivesSeveral methodological problems arise when health outcomes and resource utilization are collected at different sites. To avoid misleading conclusions in multi-center economic evaluations the center effect needs to be taken into adequate consideration. The aim of this article is to compare several models, which make use of a different amount of information about the enrolling center.MethodsTo model the association of total medical costs with the levels of two sets of covariates, one at patient and one at center level, we considered four statistical models, based on the Gamma model in the class of the Generalized Linear Models with a log link, which use different amount of information on the enrolling centers. Models were ap...
Multi-center clinical trials are very common in the development of new drugs and devices. One concer...
Multi-center clinical trials are very common in the development of new drugs and devices. One concer...
Economic evaluations must use appropriate costing methods. However, in multicentre cost-effectivenes...
OBJECTIVES: Several methodological problems arise when health outcomes and resource utilization ar...
AbstractObjectivesSeveral methodological problems arise when health outcomes and resource utilizatio...
Objectives: Assessments of health technologies increasingly include economic evaluations conducted a...
Differences in the mean, spread and skewness of cost data collected from different countries present...
Cost-effectiveness analysis (CEA) in health care is increasingly conducted alongside multicentre and...
We consider statistical methods for benchmarking clinical centers based on a dichotomous outcome ind...
Multicentre studies are common in epidemiological research aiming at identifying disease risk factor...
Abstract Background Multicentre randomized controlled trials (RCTs) routinely use randomization and ...
Multicentre studies are common in epidemiological research aiming at identifying disease risk factor...
Objective: To estimate the importance of center and provider effect and its implication on the estim...
Clinical trials of rare diseases commonly enlist several centers to achieve recruitment goals. The a...
Objective: To estimate the importance of center and provider effect and its implication on the estim...
Multi-center clinical trials are very common in the development of new drugs and devices. One concer...
Multi-center clinical trials are very common in the development of new drugs and devices. One concer...
Economic evaluations must use appropriate costing methods. However, in multicentre cost-effectivenes...
OBJECTIVES: Several methodological problems arise when health outcomes and resource utilization ar...
AbstractObjectivesSeveral methodological problems arise when health outcomes and resource utilizatio...
Objectives: Assessments of health technologies increasingly include economic evaluations conducted a...
Differences in the mean, spread and skewness of cost data collected from different countries present...
Cost-effectiveness analysis (CEA) in health care is increasingly conducted alongside multicentre and...
We consider statistical methods for benchmarking clinical centers based on a dichotomous outcome ind...
Multicentre studies are common in epidemiological research aiming at identifying disease risk factor...
Abstract Background Multicentre randomized controlled trials (RCTs) routinely use randomization and ...
Multicentre studies are common in epidemiological research aiming at identifying disease risk factor...
Objective: To estimate the importance of center and provider effect and its implication on the estim...
Clinical trials of rare diseases commonly enlist several centers to achieve recruitment goals. The a...
Objective: To estimate the importance of center and provider effect and its implication on the estim...
Multi-center clinical trials are very common in the development of new drugs and devices. One concer...
Multi-center clinical trials are very common in the development of new drugs and devices. One concer...
Economic evaluations must use appropriate costing methods. However, in multicentre cost-effectivenes...